<\/p>\n
Rivamer<\/strong> is an oral capsule from Sun Pharma containing rivastigmine 1.5 mg<\/strong> — a dual acetylcholinesterase + butyrylcholinesterase inhibitor<\/strong> utilizat pentru tratamentul simptomatic al boal\u0103 Alzheimer u\u0219oar\u0103 p\u00e2n\u0103 la moderat\u0103<\/strong> AND Demen\u021ba \u00een boala Parkinson<\/strong> (the only AChE inhibitor licensed for PDD). Slow titration: 1.5 mg twice daily for 2 weeks → 3 mg twice daily for 2 weeks → 4.5 mg twice daily for 2 weeks → 6 mg twice daily maintenance<\/strong>. Always take with food.<\/strong> The transdermal patch (not stocked here) significantly reduces GI side effects and is preferred for patients who cannot tolerate the oral form.<\/p>\n<\/div>\n \ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n Rivamer is an oral capsule from Sun Pharma containing rivastigmine tartrate 1.5 mg<\/strong>. Rivastigmine is a pseudo-irreversible dual cholinesterase inhibitor<\/strong> — it inhibits both acetylcholinesterase (AChE)<\/strong> \u0219i butyrylcholinesterase (BuChE)<\/strong>. The dual mechanism distinguishes it from donepezil and galantamine, which only inhibit AChE.<\/p>\n Rivamer from Sun Pharma is a 1.5 mg rivastigmine capsule — the starting dose for the 6–8 week titration in mild-to-moderate Alzheimer's and Parkinson's disease dementia. Titrate to the maintenance 12 mg\/day dose. Always take with food to minimise the GI side effects that are characteristic of oral rivastigmine. Rivastigmine is the only cholinesterase inhibitor with a licensed indication for Demen\u021ba \u00een boala Parkinson<\/strong> in addition to mild-to-moderate Alzheimer's. The dual ACh + BuChE inhibition may matter more in PDD because BuChE activity is relatively preserved in PD compared with Alzheimer's.<\/p>\n Both Alzheimer's disease and Parkinson's disease dementia involve cholinergic neuron loss. Rivastigmine raises synaptic acetylcholine through dual enzymatic inhibition:<\/p>\n Apariere a beneficiului cognitiv: observabil\u0103 la 6\u201312 s\u0103pt\u0103m\u00e2ni<\/strong> on the maintenance 9–12 mg\/day dose; peak at 6 months.<\/p>\n Rivamer is prime\u0219te,<\/strong> indicated for: severe Alzheimer's disease (only donepezil is licensed at this stage), mild cognitive impairment, frontotemporal dementia (worsens behavioural symptoms), or as a cognitive enhancer in healthy adults.<\/p>\n Rivamer comes at 1.5 mg<\/strong> capsules. The 6–8 week titration is mandatory — rivastigmine has the most aggressive GI profile of all AChE inhibitors when given orally.<\/p>\n Standard 6–8 week titration:<\/strong><\/p>\n Common (highest GI burden of all oral AChE inhibitors):<\/strong><\/p>\n Mai pu\u021bin frecvente, dar importante:<\/strong><\/p>\n Rare dar necesita aten\u021bie medical\u0103:<\/strong><\/p>\nDe ce s\u0103 comanzi de la MedsBase<\/h3>\n
What Is Rivamer?<\/h2>\n
How Does Rivamer Work?<\/h2>\n
\n
Utiliz\u0103ri \u0219i indica\u021bii<\/h2>\n
\n
Rivamer Dosage and How to Take — SLOW TITRATION<\/h2>\n
\n
How to Take Rivamer Properly<\/h3>\n
\n
Side Effects of Rivamer<\/h2>\n
\n
\n
\n
Avertismente \u0219i precau\u021bii<\/h2>\n
\n
Contraindications — Who Should NOT Take Rivamer<\/h2>\n
\n
Interac\u021biuni medicamentoase<\/h2>\n